{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:07:24Z","timestamp":1763737644247,"version":"3.45.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Dokuz Eylul University Scientific Research Projects Coordination Unit","award":["TSG-2022-2576","TSG-2022-2576"],"award-info":[{"award-number":["TSG-2022-2576","TSG-2022-2576"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02403-8","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:12:52Z","timestamp":1763734372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of FXa could be a novel therapeutic target associated with hypoxia-associated tumor behavior?"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6223-1272","authenticated-orcid":false,"given":"Ozge","family":"Bayrak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1627-1548","authenticated-orcid":false,"given":"Nazl\u0131","family":"Mert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9439-2217","authenticated-orcid":false,"given":"Yasemin","family":"Basbinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1458-9023","authenticated-orcid":false,"given":"Serdar","family":"Bayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"Suppl 5","key":"2403_CR1","first-page":"SP20","volume":"17","author":"X Song","year":"2011","unstructured":"Song X. Characterizing medical care by disease phase in metastatic colorectal cancer. Am J Manag Care. 2011;17(Suppl 5):SP20\u20135.","journal-title":"Am J Manag Care"},{"issue":"8","key":"2403_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/cancers11081103","volume":"11","author":"M Arce","year":"2019","unstructured":"Arce M, Pinto MP, Galleguillos M, Mu\u00f1oz C, Lange S, Ramirez C, Erices R, Gonzalez P, Velasquez E, Tempio F, Lopez MN, Salazar-Onfray F, Cautivo K, Kalergis AM, Cruz S, Lladser \u00c1, Lobos-Gonz\u00e1lez L, Valenzuela G, Olivares N, Owen GI. Coagulation factor Xa promotes solid tumor growth, experimental metastasis, and endothelial cell activation. Cancers. 2019;11(8):1103. https:\/\/doi.org\/10.3390\/cancers11081103.","journal-title":"Cancers"},{"issue":"6","key":"2403_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/10245330701521416","volume":"12","author":"S Molnar","year":"2007","unstructured":"Molnar S, Guglielmone H, Lavarda M, Rizzi ML, Jarchum G. Procoagulant factors in patients with cancer. Hematology. 2007;12(6):555\u20139. https:\/\/doi.org\/10.1080\/10245330701521416.","journal-title":"Hematology"},{"key":"2403_CR4","doi-asserted-by":"publisher","first-page":"909767","DOI":"10.3389\/fonc.2022.909767","volume":"12","author":"W Strasenburg","year":"2022","unstructured":"Strasenburg W, J\u00f3\u017awicki J, Dur\u015blewicz J, Kuffel B, Kulczyk MP, Kowalewski A, Grzanka D, Drewa T, Adamowicz J. Tumor cell-induced platelet aggregation as an emerging therapeutic target for cancer therapy. Front Oncol. 2022;12:909767. https:\/\/doi.org\/10.3389\/fonc.2022.909767.","journal-title":"Front Oncol"},{"issue":"5","key":"2403_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22052304","volume":"22","author":"B Heissig","year":"2021","unstructured":"Heissig B, Salama Y, Osada T, Okumura K, Hattori K. The multifaceted role of plasminogen in cancer. Int J Mol Sci. 2021;22(5):1\u201310. https:\/\/doi.org\/10.3390\/ijms22052304.","journal-title":"Int J Mol Sci"},{"key":"2403_CR6","doi-asserted-by":"publisher","first-page":"605314","DOI":"10.3389\/fonc.2020.605314","volume":"10","author":"CN Hill","year":"2020","unstructured":"Hill CN, Hern\u00e1ndez-C\u00e1ceres MP, Asencio C, Torres B, Solis B, Owen GI. Deciphering the role of the coagulation cascade and autophagy in cancer-related thrombosis and metastasis. Front Oncol. 2020;10:605314. https:\/\/doi.org\/10.3389\/fonc.2020.605314.","journal-title":"Front Oncol"},{"issue":"4","key":"2403_CR7","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/IGC.0b013e3182150e98","volume":"21","author":"Z Ma","year":"2011","unstructured":"Ma Z, Zhang T, Wang R, Cheng Z, Xu H, Li W, Wang Y, Wang X. Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism. Int J Gynecol Cancer. 2011;21(4):616\u201324. https:\/\/doi.org\/10.1097\/IGC.0b013e3182150e98.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"2403_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bbrc.2012.03.140","volume":"421","author":"A Dutra-Oliveira","year":"2012","unstructured":"Dutra-Oliveira A, Monteiro RQ, Mariano-Oliveira A. Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1\/2 pathway in human glioblastoma cell lines. Biochem Biophys Res Commun. 2012;421(2):221\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2012.03.140.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2403_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11481-014-9531-7","volume":"9","author":"S Ramakrishnan","year":"2014","unstructured":"Ramakrishnan S, Anand V, Roy S. Vascular endothelial growth factor signaling in hypoxia and inflammation. J Neuroimmune Pharmacol. 2014;9(2):142\u201360. https:\/\/doi.org\/10.1007\/s11481-014-9531-7.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"3","key":"2403_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10863-007-9080-3","volume":"39","author":"R Bartrons","year":"2007","unstructured":"Bartrons R, Caro J. Hypoxia, glucose metabolism and the Warburg\u2019s effect. J Bioenerg Biomembr. 2007;39(3):223\u20139. https:\/\/doi.org\/10.1007\/s10863-007-9080-3.","journal-title":"J Bioenerg Biomembr"},{"issue":"5","key":"2403_CR11","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/sj.bjc.6601205","volume":"89","author":"MI Koukourakis","year":"2003","unstructured":"Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer. 2003;89(5):877\u201385. https:\/\/doi.org\/10.1038\/sj.bjc.6601205.","journal-title":"Br J Cancer"},{"issue":"9","key":"2403_CR12","doi-asserted-by":"publisher","first-page":"e74853","DOI":"10.1371\/journal.pone.0074853","volume":"8","author":"R Lu","year":"2013","unstructured":"Lu R, Jiang M, Chen Z, Xu X, Hu H, Zhao X, Gao X, Guo L. Lactate dehydrogenase 5 expression in non-hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis. PLoS ONE. 2013;8(9):e74853. https:\/\/doi.org\/10.1371\/journal.pone.0074853.","journal-title":"PLoS ONE"},{"issue":"1","key":"2403_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bpa.12299","volume":"26","author":"CJ Valvona","year":"2016","unstructured":"Valvona CJ, Fillmore HL, Nunn PB, Pilkington GJ. The Regulation and function of lactate dehydrogenase A: therapeutic potential in brain tumor. Brain Pathol. 2016;26(1):3\u201317. https:\/\/doi.org\/10.1111\/bpa.12299.","journal-title":"Brain Pathol"},{"key":"2403_CR14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5484","author":"S Bratsos","year":"2019","unstructured":"Bratsos S. Pharmacokinetic properties of rivaroxaban in healthy human subjects. Cureus. 2019. https:\/\/doi.org\/10.7759\/cureus.5484.","journal-title":"Cureus"},{"issue":"1","key":"2403_CR15","doi-asserted-by":"publisher","first-page":"27034","DOI":"10.1038\/s41598-024-76947-0","volume":"14","author":"MW Helmy","year":"2024","unstructured":"Helmy MW, Youssef MH, Yamari I, Amr A, Moussa FI, El Wakil A, Chtita S, El-Samad LM, Hassan MA. Repurposing of sericin combined with dactolisib or vitamin D to combat non-small lung cancer cells through computational and biological investigations. Sci Rep. 2024;14(1):27034. https:\/\/doi.org\/10.1038\/s41598-024-76947-0.","journal-title":"Sci Rep"},{"issue":"D1","key":"2403_CR16","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE. PubChem 2023 update. Nucleic Acids Res. 2023;51(D1):D1373\u201380. https:\/\/doi.org\/10.1093\/nar\/gkac956.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2403_CR17","doi-asserted-by":"publisher","first-page":"D564","DOI":"10.1093\/nar\/gkae1091","volume":"53","author":"SK Burley","year":"2025","unstructured":"Burley SK, Bhatt R, Bhikadiya C, Bi C, Biester A, Biswas P, Bittrich S, Blaumann S, Brown R, Chao H, Chithari VR, Craig PA, Crichlow GV, Duarte JM, Dutta S, Feng Z, Flatt JW, Ghosh S, Goodsell DS, Green RK, Guranovic V, Henry J, Hudson BP, Joy M, Kaelber JT, Khokhriakov I, Lai J-S, Lawson CL, Liang Y, Myers-Turnbull D, Peisach E, Persikova I, Piehl DW, Pingale A, Rose Y, Sagendorf J, Sali A, Segura J, Sekharan M, Shao C, Smith J, Trumbull M, Vallat B, Voigt M, Webb B, Whetstone S, Wu-Wu A, Xing T, Young JY, Zalevsky A, Zardecki C. Updated resources for exploring experimentally-determined PDB structures and computed structure models at the RCSB Protein Data Bank. Nucleic Acids Res. 2025;53(D1):D564\u201374. https:\/\/doi.org\/10.1093\/nar\/gkae1091.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2403_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334.AutoDock","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson A. NIH public access. J Comput Chem. 2010;31(2):455\u201361. https:\/\/doi.org\/10.1002\/jcc.21334.AutoDock.","journal-title":"J Comput Chem"},{"key":"2403_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-024-01011-0","author":"RV Honorato","year":"2024","unstructured":"Honorato RV, Trellet ME, Jim\u00e9nez-Garc\u00eda B, Schaarschmidt JJ, Giulini M, Reys V, Koukos PI, Rodrigues JPGLM, Karaca E, van Zundert GCP, Roel-Touris J, van Noort CW, Jandov\u00e1 Z, Melquiond ASJ, Bonvin AMJJ. The HADDOCK2.4 web server for integrative modeling of biomolecular complexes. Nat Protocols. 2024. https:\/\/doi.org\/10.1038\/s41596-024-01011-0.","journal-title":"Nat Protocols"},{"issue":"1","key":"2403_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"RA Laskowski","year":"2018","unstructured":"Laskowski RA, Jab\u0142o\u0144ska J, Pravda L, Va\u0159ekov\u00e1 RS, Thornton JM. PDBsum: structural summaries of PDB entries. Protein Sci. 2018;27(1):129\u201334. https:\/\/doi.org\/10.1002\/pro.3289.","journal-title":"Protein Sci"},{"key":"2403_CR21","unstructured":"MN Natural Resources Research Institute. DO\/%Saturation Calculator. https:\/\/www.waterontheweb.org\/under\/waterquality\/dosatcalc.html."},{"issue":"4","key":"2403_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin","year":"2008","unstructured":"Kaelin WG, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30(4):393\u2013402. https:\/\/doi.org\/10.1016\/j.molcel.2008.04.009.","journal-title":"Mol Cell"},{"issue":"10","key":"2403_CR23","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4161\/cbt.10.10.13236","volume":"10","author":"K DeFeo","year":"2010","unstructured":"DeFeo K, Hayes C, Chernick M, Van Ryn J, Gilmour SK. Use of dabigatran etexilate to reduce breast cancer progression. Cancer Biol Ther. 2010;10(10):1001\u20138. https:\/\/doi.org\/10.4161\/cbt.10.10.13236.","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"2403_CR24","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1080\/15384047.2015.1078025","volume":"16","author":"ET Alexander","year":"2015","unstructured":"Alexander ET, Minton AR, Hayes CS, Goss A, Van Ryn J, Gilmour SK. Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis. Cancer Biol Ther. 2015;16(12):1802\u201311. https:\/\/doi.org\/10.1080\/15384047.2015.1078025.","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"2403_CR25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/jth.14443","volume":"17","author":"JT Buijs","year":"2019","unstructured":"Buijs JT, Laghmani EH, van den Akker RFP, Tieken C, Vletter EM, van der Molen KM, Crooijmans JJ, Kroone C, Le D\u00e9v\u00e9dec SE, van der Pluijm G, Versteeg HH. The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice. J Thromb Haemost. 2019;17(6):951\u201363. https:\/\/doi.org\/10.1111\/jth.14443.","journal-title":"J Thromb Haemost"},{"key":"2403_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2119\/molmed.2016.00214","volume":"23","author":"K Shi","year":"2017","unstructured":"Shi K, Damhofer H, Daalhuisen J, Brink MT, Richel DJ, Spek CA. Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice. Mol Med. 2017;23:13\u201323. https:\/\/doi.org\/10.2119\/molmed.2016.00214.","journal-title":"Mol Med"},{"issue":"6","key":"2403_CR27","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/j.thromres.2010.02.018","volume":"125","author":"K Borensztajn","year":"2010","unstructured":"Borensztajn K, Peppelenbosch MP, Spek CA. Coagulation factor Xa inhibits cancer cell migration via LIMK1-mediated cofilin inactivation. Thromb Res. 2010;125(6):e323\u20138. https:\/\/doi.org\/10.1016\/j.thromres.2010.02.018.","journal-title":"Thromb Res"},{"issue":"2","key":"2403_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.thromres.2009.01.015","volume":"124","author":"K Borensztajn","year":"2009","unstructured":"Borensztajn K, Bijlsma MF, Reitsma PH, Peppelenbosch MP, Spek CA. Coagulation factor Xa inhibits cancer cell migration via protease-activated receptor-1 activation. Thromb Res. 2009;124(2):219\u201325. https:\/\/doi.org\/10.1016\/j.thromres.2009.01.015.","journal-title":"Thromb Res"},{"issue":"1","key":"2403_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-020-04675-7","volume":"21","author":"J Castle","year":"2020","unstructured":"Castle J, Blower E, Bundred NJ, Harvey JR, Thachil J, Marshall A, Cox K, Cicconi S, Holcombe C, Palmieri C, Kirwan CC. Rivaroxaban compared to no treatment in ER-negative stage I-III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial. Trials. 2020;21(1):1\u201311. https:\/\/doi.org\/10.1186\/s13063-020-04675-7.","journal-title":"Trials"},{"issue":"1","key":"2403_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/cancers11010100","volume":"11","author":"CJ Reddel","year":"2019","unstructured":"Reddel CJ, Tan CW, Chen VM. Thrombin generation and cancer: contributors and consequences. Cancers. 2019;11(1):100. https:\/\/doi.org\/10.3390\/cancers11010100.","journal-title":"Cancers"},{"key":"2403_CR31","doi-asserted-by":"publisher","first-page":"20908","DOI":"10.1038\/s41598-020-77963-6","volume":"10","author":"MA Mohammad","year":"2020","unstructured":"Mohammad MA. Activation of PAR2 by tissue factor induces the release of the PTEN from MAGI proteins and regulates PTEN and Akt activities. Sci Rep. 2020;10:20908.","journal-title":"Sci Rep"},{"issue":"1","key":"2403_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2014.12.035","volume":"358","author":"K Augoff","year":"2015","unstructured":"Augoff K, Hryniewicz-Jankowska A, Tabola R. Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer. Cancer Lett. 2015;358(1):1\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2014.12.035.","journal-title":"Cancer Lett"},{"issue":"3","key":"2403_CR33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cell.2015.03.011","volume":"161","author":"DC Lee","year":"2015","unstructured":"Lee DC, Sohn HA, Park ZY, Oh S, Kang YK, Lee KM, Kang M, Jang YJ, Yang SJ, Hong YK, Noh H, Kim JA, Kim DJ, Bae KH, Kim DM, Chung SJ, Yoo HS, Yu DY, Park KC, Yeom YI. A lactate-induced response to hypoxia. Cell. 2015;161(3):595\u2013609. https:\/\/doi.org\/10.1016\/j.cell.2015.03.011.","journal-title":"Cell"},{"issue":"22","key":"2403_CR34","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","volume":"71","author":"F Hirschhaeuser","year":"2011","unstructured":"Hirschhaeuser F, Sattler UGA, Mueller-Klieser W. Lactate: a metabolic key player in cancer. Cancer Res. 2011;71(22):6921\u20135. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1457.","journal-title":"Cancer Res"},{"issue":"1","key":"2403_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.18632\/oncotarget.211","volume":"2","author":"GJ Villares","year":"2011","unstructured":"Villares GJ, Zigler M, Bar-Eli M. The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis\u2014a possible therapeutic target. Oncotarget. 2011;2(1):8\u201317.","journal-title":"Oncotarget"},{"key":"2403_CR36","first-page":"137","volume":"6","author":"J Liu","year":"2016","unstructured":"Liu J, et al. E-cadherin expression in cancer: implications for metastasis. Front Oncol. 2016;6:137.","journal-title":"Front Oncol"},{"issue":"63","key":"2403_CR37","doi-asserted-by":"publisher","first-page":"107334","DOI":"10.18632\/oncotarget.21015","volume":"8","author":"X Liu","year":"2017","unstructured":"Liu X, Yu J, Song S, Yue X, Li Q. Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer. Oncotarget. 2017;8(63):107334.","journal-title":"Oncotarget"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02403-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02403-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02403-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:12:54Z","timestamp":1763734374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02403-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2403"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02403-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2138"}}